Ocean Biomedical, Inc.
OCEA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3,791 | $38,825 | $68,766 | $82,799 |
| - Cash | $0 | $0 | $0 | $4 |
| + Debt | $9,350 | $16,300 | $12,838 | $10,980 |
| Enterprise Value | $13,141 | $55,125 | $81,604 | $93,775 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7,897 | $716 | -$5,067 | -$16,719 |
| % Margin | – | – | – | – |
| Net Income | -$8,240 | $283 | -$5,528 | -$17,234 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | 0.01 | -0.2 | -0.63 |
| % Growth | -3,100% | 105% | 68.3% | – |
| Operating Cash Flow | -$356 | -$2,520 | -$885 | -$290 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$356 | -$2,520 | -$885 | -$290 |